Aspire Biopharma Holdings Inc
Officers & Directors
For the year ended December 31, 2025, the executive officers were Kraig T. Higginson, Chief Executive Officer, and Ernest J. Scheidemann, Jr., Chief Financial Officer. In 2025, Kraig T. Higginson received a salary of $135,000 and a bonus of $120,000. Ernest J. Scheidemann, Jr. received a salary of $220,000 and a bonus of $100,000. Employment agreements specify an annual base salary of $180,000 for Mr. Higginson and $240,000 for Mr. Scheidemann, both subject to annual review. Both officers are eligible for performance-based bonuses, employee benefits, paid time off, reimbursement of business expenses, and other fringe benefits. The agreements include non-disparagement, confidentiality, invention assignment, non-interference, and non-solicitation covenants, as well as severance provisions applicable if terminated without cause or resignation for good reason. Michael G. Howe, former Chief Executive Officer, received $37,500 in cash compensation in 2025.
Aspire Biopharma Holdings Inc currently has 45 employees.
|
